Evaluation of the Argos System to Estimate Cardiac Output

Recruiting now

Conditions studied: Shock

In brief

The goal of this observational study is to evaluate the reliability of the Argos system to track changes in cardiac output in critically ill patients. The main question it aims to answer is: Does cardiac output changes induced by fluid administration or changes in norepinephrine dosage can be tracked by the Argos system, compared to transpulmonary thermodilution device.

Key facts

Study ID

NCT07724262

Run by

Bicetre Hospital

People needed

120

Starts

2026-02-01

Expected to finish

2027-01-31

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years old
• Hospitalisation in intensive care
• Haemodynamic monitoring with transpulmonary thermodilution already in place
• Hemodynamic intervention deemed necessary by the clinician in charge of the patient
• Administration of a fluid bolus
• Change in norepinephrine dosage or performance of a vasopressor test

You may not qualify if…

• Pregnancy
• Other therapeutic modification during volume expansion or the vasopressor test
• Refusal to participate by relatives of the patient or the patient himself or herself
• Non availability of investigators

Where it is running

• Bicêtre Hospital — Le Kremlin-Bicêtre, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.